EDGAR Filing Documents for 0000912057-15-000051

Form DRS/A - Draft Registration Statement: [Amend]

SEC Accession No. 0000912057-15-000051

Filing Date

2015-03-05

Accepted

2015-03-05 12:11:54

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.htm	DRS/A	1927722
2		filename2.htm	EX-3.4	211461
3		filename3.htm	EX-10.17	101457
4		g130958.jpg	GRAPHIC	44686
5		g141214.jpg	GRAPHIC	18054
6		g215279.jpg	GRAPHIC	22739
7		g239265.jpg	GRAPHIC	70378
8		g349605.jpg	GRAPHIC	41624
9		g434493.jpg	GRAPHIC	57157
10		g476553.jpg	GRAPHIC	22748
11		g477145.jpg	GRAPHIC	18785
12		g493108.jpg	GRAPHIC	40509
13		g561315.jpg	GRAPHIC	49960
14		g573488.jpg	GRAPHIC	14418
15		g589761.jpg	GRAPHIC	74445
16		g634352.jpg	GRAPHIC	56008
17		g664220.jpg	GRAPHIC	9965
18		g664658.jpg	GRAPHIC	51741
19		g765920.jpg	GRAPHIC	25458
20		g828095.jpg	GRAPHIC	18161
21		g884541.jpg	GRAPHIC	14329
22		g900575.jpg	GRAPHIC	27982
23		g927875.jpg	GRAPHIC	25056
24		g995880.jpg	GRAPHIC	20153
	Complete submission text file	0000912057-15-000051.txt		3242168

Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139

Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971

CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)